Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01842542 · ClinicalTrials.gov registry record · NA
Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset
A NA study, sponsored by Neuronetics.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01842542 is a NA study that was terminated before completion, run by Neuronetics. The registered enrollment target is 25 participants.
The verdict
NCT01842542, a NA study, was terminated before completion, sponsored by Neuronetics.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of acute NeuroStar TMS therapy in women who have postpartum depression.
Interventions
- DEVICE NeuroStar Transcranial Magnetic Stimulation (TMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842542
The ClinicalTrials.gov registry entry for NCT01842542 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroStar Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT01842542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01842542 about?
NCT01842542 is a clinical study titled "Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset". The purpose of this study is to evaluate the safety and effectiveness of acute NeuroStar TMS therapy in women who have postpartum depression.
What is the current status of trial NCT01842542?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2013-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01842542?
The interventions under investigation include: NeuroStar Transcranial Magnetic Stimulation (TMS) (DEVICE).
Who is sponsoring clinical trial NCT01842542?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.